Intellipharmaceutics International Inc (IPCIF) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IPCIF Annual Balance Sheets →
Examining balance sheet movements between Intellipharmaceutics International Inc and May 31 2023 reveals how Nov 30 2022 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Nov 30 2022)
0 (Aug 31 2023) 0 (May 31 2023)
Assets
Cash & cash equivalent0.08
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Current Assets0.27
Prepaid Expense And Other Assets Current0.01
Total Current Assets0.49
Equipment/Property/Plant Net6.68
Tax Assets, Noncurrent0.32
Other Assets, Noncurrent0.00
Total Assets1.43
Liabilities
Accounts Payable, Current AC2.78
Employee-related Liabilities, Current AC2.27
Notes and Loans Payable, Current LO0.36
Taxes Payable, Current, Total0.03
Deferred Revenue, Current DE0.00
Total Current Liabilities8.87
Long-term debt0.36
Convertible Notes Payable NO1.80
Total Long-term Debt2.16
Accrued Income Taxes, Noncurrent0.27
Other liabilities, Noncurrent10.21
Total Liabilities8.87
Stockholders' Equity
Common Stock Value36.32
Additional Paid In Capital Common Stock33.31
Retained Earnings / Accumulated Deficit-77.66
Accumulated Other Comprehensive Income0.28
Other Equity0.28
Common Stockholder's Equity-7.81
Total Stockholder's Equity-7.81
Liabilities & Stockholder's Equity1.43
4 historic quarters locked

Sign in to unlock the full Intellipharmaceutics International Inc balance sheet history.

About Intellipharmaceutics International Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001654954-23-008028

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.